The True Cost of Reproductive & Hormonal Health in Your Workforce
Menstrual health, perimenopause, menopause, endometriosis, PMDD, and PCOS cost employers billions in lost productivity and avoidable surgeries. See how much you could save with Samphire.
The True Cost of Reproductive & Hormonal Health in Your Workforce
Menstrual health, perimenopause, menopause, endometriosis, PMDD, and PCOS cost employers billions in lost productivity and avoidable surgeries. See how much you could save with Samphire.
Your Workforce
Estimated annual program cost: $31,500
Based on 30 enrolled employees at $1,050/employee
Savings Breakdown by Category
| Category | Annual Cost | Savings |
|---|---|---|
| Menstrual health productivity | $349,489 | $111,836 |
| Perimenopause & menopause | $59,892 | $14,973 |
| Endometriosis (incremental) | $23,322 | $6,997 |
| PMDD (incremental) | $13,089 | $3,927 |
| PCOS (incremental) | $12,891 | $3,867 |
| Surgery & recoveryavoided | $79,291 | $19,823 |
| Turnover | $123,750 | $24,750 |
Cost per Employee in Context
EAP: 3–5% utilization typical. Employer health spend per KFF 2024.
Want a personalised report?
Get a detailed PDF breakdown tailored to your workforce.
Sources
- Schoep ME, et al. (2019). "Productivity loss due to menstruation-related symptoms." BMJ Open. DOI: 10.1136/bmjopen-2018-026186
- Ponzo S, et al. (2022). "Menstrual cycle-associated symptoms and workplace productivity in US employees." Digital Health. DOI: 10.1177/20552076221145852
- Nnoaham KE, et al. (2011). "Impact of endometriosis on quality of life and work productivity." Fertility and Sterility. DOI: 10.1016/j.fertnstert.2011.05.090
- Fourquet J, et al. (2010). "Patients' report on how endometriosis affects health, work, and daily life." Fertility and Sterility. DOI: 10.1016/j.fertnstert.2009.09.017
- Simoens S, et al. (2012). "The burden of endometriosis: costs and quality of life." Human Reproduction Update. DOI: 10.1093/humupd/dms029
- Halbreich U, et al. (2003). "The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder." Psychoneuroendocrinology. DOI: 10.1016/S0306-4530(03)00098-2
- Bozdag G, et al. (2016). "The prevalence and phenotypic features of polycystic ovary syndrome." Human Reproduction Update. DOI: 10.1093/humrep/dew218
- CIPD (2023). Menopause in the Workplace. Survey Report.
- Fawcett Society (2022). Menopause and the Workplace.
- SHRM (2022). Average Cost-per-Hire for Companies.
- Bureau of Labor Statistics — annual turnover rates.
- KFF (2024). Employer Health Benefits Survey.
Calculation Methodology
The calculator models six cost categories across four population segments:
Menstrual health costs (absenteeism + presenteeism) apply to reproductive-age female employees based on Schoep et al. and Ponzo et al.
Perimenopause & menopause costs apply to the peri/menopausal segment using CIPD and Fawcett Society data on symptom-related absenteeism, presenteeism, and brain fog productivity loss.
Condition-specific incremental costs capture the additional productivity burden for employees with endometriosis, PMDD, and PCOS beyond the population-level averages.
Surgery & recovery costs model the employer burden of condition-related surgeries including recovery time off and direct employer costs.
Turnover costs estimate departures attributable to inadequate reproductive health support across all female employees.
Disclaimer: This calculator provides estimates based on published research. Actual results will vary based on your workforce demographics, industry, and implementation. Samphire effectiveness estimates are based on conservative projections. Condition prevalence rates represent population averages; overlap between conditions means actual affected headcount may be lower than the sum of individual estimates. All figures are in USD.